M. Ho

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma

Chung‐Wei Su, Wei Teng, Po‐Ting Lin et al. · Cancer Medicine · 2022 · 33 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Combination of crafity score with alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Wei Teng, Chen‐Chun Lin, Po Ting Lin et al. · Journal of Hepatology · 2022 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma.

Wei Teng, Chen‐Chun Lin, M. Ho et al. · PubMed · 2021 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1, irRC, and iRECIST criteria: comparison with subjective assessment

Ying‐Chieh Lai, Wen‐Cheng Chang, Chun‐Bing Chen et al. · Acta Radiologica · 2019 · 17 citations

Medicine, Oncology, Radiology +15

Albumin and Neutrophil-to-Lymphocyte Ratio Score in Neoadjuvant Concurrent Chemoradiotherapy for Esophageal Cancer: Comparison With Prognostic Nutritional Index

William Hsueh, Shun‐Wen Hsueh, Kun‐Yun Yeh et al. · In Vivo · 2022 · 13 citations · Full text

Medicine, Oncology, Cancer Immunology +16